Privacy Act; Implementation, 2633-2636 [2020-28884]
Download as PDF
Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Proposed Rules
(ii) The pregnant woman’s informed
consent be obtained by an individual
other than the individual who obtained
the informed consent for the pregnant
woman’s abortion;
(iii) The pregnant woman be at or over
the age of majority in the jurisdiction in
which the pregnant woman’s donation
is made; and
(iv) The Informed Consent Form
include a statement that the decision to
have an abortion and the method of
abortion have not been affected by the
decision whether to donate human fetal
tissue.
■ 4. Amend § 46.206 by adding
paragraphs (c) through (i) to read as
follows:
§ 46.206 Research involving, after delivery,
the placenta, the dead fetus or fetal
material.
*
*
*
*
*
(c) At all stages in the process to
acquire or otherwise obtain human fetal
tissue for use in research, there shall be
no enticements, benefits, or financial
incentives provided to the pregnant
woman or attending physician to
incentivize the occurrence of an
abortion or the donation or acquisition
of human fetal tissue.
(d) No person who solicits or
knowingly acquires, receives, or accepts
a donation of human fetal tissue for use
in research shall provide valuable
consideration for the costs associated
with the abortion that is the source of
the human fetal tissue used or to be
used in the research.
(e) No person who solicits or
knowingly acquires, receives, or accepts
a donation of human fetal tissue for use
in research shall provide valuable
consideration for the costs associated
with the donation or acquisition of
human fetal tissue.
(f) For purposes of paragraphs (d) and
(e) of this section, the term ‘‘valuable
consideration’’ includes all payments
other than reasonable payments
associated with the transportation,
implantation, processing, preservation,
quality control, or storage of human
fetal tissue.
(g) Human fetal tissue obtained by
donation from a woman occurring after
[the effective date of the final rule] may
be used in research only if an informed
consent that meets the applicable
requirements of § 46.204(k) has been
obtained with respect to the tissue.
(h) Research involving human fetal
tissue can use human fetal tissue from
elective abortions only if such tissue is
acquired or otherwise obtained from a
Federal or State Government, a Federal
or State Government-owned entity,
university, college, accredited degree-
VerDate Sep<11>2014
17:44 Jan 12, 2021
Jkt 253001
granting institution of higher education,
university hospital, or academic
medical center.
(i) Once human fetal tissue is no
longer to be used in research, it shall be
treated respectfully and disposed of
reasonably and in compliance with any
additional laws or regulations imposed
by applicable state law.
PART 75—UNIFORM ADMINISTRATIVE
REQUIREMENTS, COST PRINCIPLES,
AND AUDIT REQUIREMENTS FOR HHS
AWARDS
5. The authority citation for 45 CFR
part 75 continues to read as follows:
■
Authority: 5 U.S.C. 301.
2633
elective abortions for use in research are
not allowable expenses under Federal
awards from an HHS awarding agency.
Dated: December 29, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2020–29107 Filed 1–11–21; 4:15 pm]
BILLING CODE 4151–26–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
45 CFR Part 5b
[Docket Number NIH–2016–0002]
RIN 0925–AA62
6. Amend § 75.364 by adding
paragraph (a)(1), adding and reserving
paragraph (a)(2) and adding paragraph
(d) to read as follows:
■
§ 75.364
Access to records.
(a) * * *
(1) For non-Federal entities that
engage in human fetal tissue research
pursuant to a Federal award, the HHS
awarding entity, Inspectors General, the
Comptroller General of the United
States, and the pass-through entity, or
any of their authorized representatives,
must have the right of access to:
(i) Copies of the informed consent
forms signed by each pregnant woman
who is the source of human fetal tissue
used by the non-Federal entity in
research, which may be redacted with
respect to the name and signature of the
woman;
(ii) all documents, papers, or other
records as are necessary to establish that
the human fetal tissue was not obtained
or transferred for valuable
consideration, as that term is defined in
45 CFR 46.206(f);
(iii) all documents, papers, or other
records as are necessary to establish that
federal funds were not used to acquire
or otherwise obtain the human fetal
tissue from elective abortions; and
(iv) personnel familiar with such
documents, for purposes of interview
and discussion concerning such
documents, at reasonable times and
locations.
(2) [Reserved]
*
*
*
*
*
(d) For purposes of this section,
‘‘human fetal tissue’’ shall have the
definition ascribed to the term in 42
U.S.C. 289g–1(g).
■ 7. Add § 75.478 to subpart E to read
as follows:
§ 75.478 Expenses associated with
acquiring human fetal tissue for research.
Expenses associated with the
acquisition of human fetal tissue from
PO 00000
Frm 00052
Fmt 4702
Sfmt 4702
Privacy Act; Implementation
Department of Health and
Human Services.
ACTION: Notice of Proposed Rulemaking.
AGENCY:
The Department of Health and
Human Services (HHS or Department)
proposes to exempt confidential source
identifying information in a system of
records maintained by the National
Institutes of Health (NIH) from certain
requirements of the Privacy Act. The
affected system of records is 09–25–
0165, ‘‘National Institutes of Health
(NIH) Office of Loan Repayment and
Scholarship (OLRS) Record System,
HHS/NIH/OD’’ (to be renamed ‘‘NIH
Loan Repayment Records’’). Elsewhere
in today’s Federal Register, HHS/NIH
has published an updated system of
records notice (SORN) for system 09–
25–0165 for public notice and comment.
DATES: Submit either electronic or
written comments regarding this
document by March 15, 2021.
ADDRESSES: You may submit comments,
identified by Docket Number NIH–
2015–0002, via any of the following
methods:
SUMMARY:
Electronic Submission
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions provided for submitting
comments.
Written Submission
Submit written submissions in the
following ways:
• Fax: 301–402–0169.
• Mail: Daniel Hernandez, Acting
NIH Regulations Officer, Office of
Management Assessment, National
Institutes of Health, 6011 Executive
Boulevard, Suite 601, MSC 7669,
Rockville, MD 20852.
In order to ensure more timely
processing of comments, HHS/NIH is no
E:\FR\FM\13JAP1.SGM
13JAP1
2634
Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Proposed Rules
longer accepting notice of proposed
rulemaking (NPRM) comments
submitted to the agency by email. HHS/
NIH encourages you to continue to
submit electronic comments by using
the Federal eRulemaking Portal, as
described previously, in the ADDRESSES
portion of this document under
Electronic Submissions.
Instructions: All submissions received
must include the agency name and
Docket No. for this rulemaking. All
comments received may be posted
without change to https://
www.regulations.gov, including any
personal information provided.
Docket: For access to the docket to
read background documents or
comments received, go to
https://www.regulations.gov and
follow the instructions provided for
conducting a search, using the docket
number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
General questions about the proposed
exemptions may be submitted to Daniel
Hernandez, Acting NIH Regulations
Officer, Office of Management
Assessment, National Institutes of
Health, 6011 Executive Boulevard, Suite
601, MSC 7669, Rockville, MD 20852,
telephone 301– 435–3343, fax 301–402–
0169, email dhernandez@od.nih.gov.
SUPPLEMENTARY INFORMATION:
I. Background on the NIH Loan
Repayment Programs and System of
Records 09–25–0165
The NIH Loan Repayment Programs
(LRPs) are administered by the Division
of Loan Repayment within NIH’s Office
of Extramural Research (HHS/NIH/OER/
DLR, hereafter referred to as DLR). DLR
provides repayment of student loans for
approved applicants to encourage
outstanding health professionals to
pursue careers in biomedical,
behavioral, social, and clinical research.
Research health professionals who owe
qualified educational debt and who
meet eligibility criteria may apply for
student loan repayment. Loan
repayments utilize a peer review
process to determine which applicants
to approve. The peer review process is
committee-based, with a peer review
group comprised of individual
reviewers, referees, or other
recommenders (hereafter collectively
referred to as reviewers). Reviewers are
primarily non-government experts
qualified by training and experience in
scientific or technical fields, or as
authorities knowledgeable in disciplines
and fields related to the areas under
review. Reviewers give DLR expert
recommendations and materials (such
VerDate Sep<11>2014
17:44 Jan 12, 2021
Jkt 253001
as ratings, summaries, and
communications) about applicants’
suitability, eligibility, or qualifications
for student loan repayments under
express promises that the reviewers will
not be identified as the sources of the
information. DLR uses the information
solely for the purpose of determining
applicants’ suitability, eligibility, or
qualifications for federal loan
repayment. System of records 09–25–
0165 covers records about health
professionals who apply for student
loan repayments and about other
categories of individuals who are related
to the applications. Records about those
record subjects include materials and
recommendations provided to DLR by
reviewers which identify, or could
enable identification of, those
confidential sources.
II. Proposed Exemptions and Affected
Records
HHS/NIH is proposing to exempt
materials about LRP applicants in
system of records 09–25–0165 from
certain provisions of the Privacy Act (5
U.S.C. 552a). The exemption applies
only to the extent that a disclosure
would reveal the identity of the
reviewer or referee who furnished
information to the Government under an
express promise that his or her identity
would be held in confidence. We
propose to exempt the system of records
from (c)(3), pertaining to the accounting
of disclosures, and (d)(1) through (d)(4),
pertaining to access, amendment, and
notification provisions, based on
subsection (k)(5) of the Act (5 U.S.C.
552a(k)(5)). Because records in system
of records 09–25–0165 contain
information not only about applicants,
but also about the reviewers, the
proposed exemptions are necessary to
enable NIH to prevent applicants from
having access to information about the
identity of individuals who provided
NIH with an expert review or referee
report under an express promise of
confidentiality. Notwithstanding the
exemptions, NIH will consider any
requests for notification, access, and
amendment that are addressed to the
System Manager, as provided in the
SORN for system of records 09–25–
0165, and to any request for an
accounting of disclosures.
Under the Privacy Act of 1974, as
amended (5 U.S.C. 552a), individuals
have access and amendment rights with
respect to records about them in a
federal agency system of records, and
the right to seek an accounting of certain
disclosures made of the records about
them, but the Act permits certain types
of systems of records (identified in
subsections (j) and (k) of the Act) to be
PO 00000
Frm 00053
Fmt 4702
Sfmt 4702
exempted from those requirements of
the Act. Subsection (k)(5) permits the
head of an agency to promulgate rules
to exempt from the requirements in 5
U.S.C. 552a(c)(3) and (d)(1) through (4)
investigatory material compiled solely
for the purpose of determining
suitability, eligibility, or qualifications
for access to federal civilian
employment, military service, federal
contracts, or access to classified
information, to the extent that the
disclosure of such material would reveal
the identity of a source who furnished
information to the government under an
express promise that the identity of the
source would be held in confidence.
Referee reports and reviews in system of
records 09–25–0165 qualify for
exemption under 5 U.S.C. 552a(k)(5),
when provided to DLR under an express
promise of confidentiality, because it is
investigatory material that DLR
compiles solely for the purpose of
determining applicants’ suitability,
eligibility, or qualifications for federal
loan repayment awards, which are
implemented by contracts.
III. Exemption Rationales
The proposed exemptions are
necessary to maintain the integrity of
the DLR peer review and award
processes, which depend on receiving
accurate, objective, and unbiased
recommendations and evaluations from
reviewers about loan repayment
applications. Protecting reviewer
identities as the sources of the
information they provide protects them
from harassment, intimidation, and
other attempts to improperly influence
award outcomes, and ensures that they
are not reluctant to provide sensitive
information or frank assessments. Case
law has held that exemptions
promulgated under subsection (k)(5)
may protect source-identifying material
even where the identity of the source is
known to the subject individual(s).
The specific rationales that support
the exemptions, as to each affected
Privacy Act provision, are as follows:
• Subsection (c)(3). An exemption
from the requirement to provide an
accounting of disclosures to record
subjects is needed to protect the identity
of any reviewer source who is expressly
promised confidentiality. Providing an
accounting of disclosures to an
individual who is related to the
application under assessment or
evaluation could identify particular
reviewers as sources of
recommendations or evaluative input
received, or to be received, on the
application. Inappropriately revealing
their identities in association with the
nature and scope of their assessments or
E:\FR\FM\13JAP1.SGM
13JAP1
Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Proposed Rules
evaluations could lead them to alter or
destroy their assessments or evaluations
or subject them to harassment,
intimidation, or other improper
influence, which would impede or
compromise the fairness and objectivity
of the loan repayment application
review process.
• Subsection (d)(1). An exemption
from the access requirement is needed
both during and after an award
application review proceeding to avoid
inappropriately revealing the identity of
any source who was expressly promised
confidentiality. Protecting these records
from access by record subjects is
necessary for the integrity of the review
process. It ensures such sources provide
candid assessments or evaluations to the
government without fear that their
identities as linked to a specific work
product will be revealed
inappropriately. Allowing an individual
applicant who is the subject of an
assessment or evaluation, or another
record subject who has a relationship to
the application, to access material that
would reveal a reviewer could interfere
with or compromise the objectivity and
fairness of award application review
proceedings, constitute an unwarranted
invasion of the personal privacy of the
reviewer, and violate the express
promise of confidentiality made to the
reviewer.
• Subsection (d)(2) through (4). An
exemption from the amendment
provisions is necessary while one or
more related application review
proceedings are pending, but only if and
to the extent that disclosure of
information in the amendment request
process would reveal inappropriately
the identity of any reviewer source who
was expressly promised confidentiality.
An exemption will be limited to
allowing the agency, when processing
an amendment request by an applicant
or other subject individual, to avoid
disclosing the existence of the record
sought to be amended and its contents,
if doing so would reveal the identity of
any reviewer who was expressly
promised confidentiality. Revealing the
identity of a reviewer to an individual
applicant or other subject individual
would interfere with the agency’s
application review process and
constitute an unwarranted invasion of
the personal privacy of the reviewer and
would violate the express promise of
confidentiality made to the reviewer.
Accordingly, pursuant to 5 U.S.C.
552a(k)(5), NIH proposes to exempt
records about particular LRP applicants
in system of records 09–25–0165 NIH
Division of Loan Repayment Record
System from the access, amendment,
and accounting of disclosures
VerDate Sep<11>2014
17:44 Jan 12, 2021
Jkt 253001
provisions of the Privacy Act (5 U.S.C.
552a(c)(3) and (d)(1) through (4)), to the
extent, and based on the specific
rationales stated above.
Notwithstanding the exemptions, NIH
will consider any request for access or
amendment that is addressed to the
System Manger as provided in the
SORN for system of records 09–25–
0165, and to any request for an
accounting of disclosures.
Analysis of Impacts
I. Review Under Executive Orders
12866, 13563, and 13771
The agency has reviewed this
proposed rule under Executive Orders
12866 and 13563, which direct agencies
to assess costs and benefits of available
regulatory alternatives and, if regulation
is necessary, to maximize the net
benefits. The agency believes that this
proposed rule is not a significant
regulatory action under Executive Order
12866, and therefore does not constitute
an E.O. 13771 regulatory action, because
it will not (1) have an annual effect on
the economy of $100 million or more or
adversely affect in a material way the
economy, a sector of the economy,
productivity, competition, jobs, the
environment, public health or safety, or
state, local or tribal governments or
communities; (2) create a serious
inconsistency or otherwise interfere
with an action taken or planned by
another agency; (3) materially alter the
budgetary impact of entitlements,
grants, user fees or loan programs, or the
rights and obligations of recipients
thereof; or (4) raise novel legal or policy
issues arising out of legal mandates, the
President’s priorities, or the principles
set forth in Executive Order 12866. legal
mandates, the President’s priorities, or
the principles set forth in Executive
Order 12866. This rule removes certain
Privacy Act rights from the subjects of
these records in accordance with criteria
established in subsection (k)(5) of the
Privacy Act (5 U.S.C. 552a(k)(5)). This
decision is based on a showing that
agency compliance with all of the
Privacy Act requirements with respect
to those records would harm the
effectiveness or integrity of the agency
function or process for which the
records are maintained (in this case,
NIH research and development loan
award processes).
II. Review Under the Regulatory
Flexibility Act (5 U.S.C. 601–612)
The Regulatory Flexibility Act
requires agencies to analyze regulatory
options that would minimize any
significant regulatory impacts of a rule
on small entities. Because the proposed
PO 00000
Frm 00054
Fmt 4702
Sfmt 4702
2635
rule imposes no duties or obligations on
small entities, we have determined, and
the Director certifies, that the proposed
rule will not have a significant
economic impact on a substantial
number of small entities.
III. Review Under the Unfunded
Mandates Reform Act of 1995 (Section
202, Pub. L. 104–4)
Section 202(a) of the Unfunded
Mandates Reform Act of 1995 requires
that agencies prepare a written
statement, which includes an
assessment of anticipated costs and
benefits, before proposing ‘‘any rule that
includes any Federal mandate that may
result in the expenditure by state, local,
and tribal governments, in the aggregate,
or by the private sector, of $100,000,000
or more (adjusted annually for inflation)
in any one year.’’ The current threshold
after adjustment for inflation is $144
million, using the most current (2015)
Implicit Price Deflator for the Gross
Domestic Product. The agency does not
expect that this proposed rule would
result in any 1-year expenditure by
state, local, and tribal governments that
would meet or exceed this amount.
IV. Review Under the Paperwork
Reduction Act of 1995 (44 U.S.C. 35–1
et seq.)
This proposed rule does not contain
any information collection requirements
subject to the Paperwork Reduction Act.
V. Review Under Executive Order
13132, Federalism
This proposed rule will not have any
direct effects on the states, on the
relationship between the National
Government and the states, or on the
distribution of power and
responsibilities among the various
levels of government. Therefore, the
requirements of Executive Order 13132
are inapplicable.
List of Subjects in 45 CFR Part 5b
Privacy.
For the reasons set out in the
preamble, the Department amends part
5b of title 45 of the Code of Federal
Regulations, as follows:
PART 5b—PRIVACY ACT
REGULATIONS
1. The authority citation for Part 5b
continues to read as follows:
■
Authority: 5 U.S.C. 301, 5 U.S.C. 552a.
2. Amend § 5b.11 by adding paragraph
(b)(2)(iv)(D) as follows:
■
§ 5b.11
*
Exempt systems.
*
*
(b) * * *
E:\FR\FM\13JAP1.SGM
13JAP1
*
*
2636
Federal Register / Vol. 86, No. 8 / Wednesday, January 13, 2021 / Proposed Rules
(2) * * *
(iv)
(D) NIH Division of Loan Repayment
Record System, 09–25–0165.
FEDERAL COMMUNICATIONS
COMMISSION
Dated: November 20, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
Approved: December 22, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[WC Docket No. 12–375; DA 20–1446; FRS
17293]
[FR Doc. 2020–28884 Filed 1–12–21; 8:45 am]
BILLING CODE 4140–01–P
47 CFR Part 64
Petition for Reconsideration of Action
in Proceeding
Correction
In proposed rule document 2020–
27982 appearing on page 83000 in the
issue of Monday, December 21, 2020,
make the following correction:
(1) On page 83000, in the second
column, in the DATES section, change
‘‘January 20, 2021’’ to read ‘‘January 21,
2021.’’
[FR Doc. C1–2020–27982 Filed 1–12–21; 8:45 am]
BILLING CODE 1301–00–D
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
50 CFR Part 218
[Docket No. 201207–0329]
RIN 0648–BJ90
Takes of Marine Mammals Incidental to
Specified Activities; Taking Marine
Mammals Incidental to U.S. Navy
Construction at Naval Station Norfolk
in Norfolk, Virginia
Correction
In proposed rule document 2020–
27300 appearing on pages 83001
through 83026 in the issue of Monday,
December 21, 2020, make the following
correction:
(1) On page 83001, in the second
column, in the DATES section, change
‘‘January 20, 2021’’ to read ‘‘January 21,
2021.’’
[FR Doc. C1–2020–27300 Filed 1–12–21; 8:45 am]
BILLING CODE 1301–00–D
VerDate Sep<11>2014
17:44 Jan 12, 2021
Jkt 253001
PO 00000
Frm 00055
Fmt 4702
Sfmt 9990
E:\FR\FM\13JAP1.SGM
13JAP1
Agencies
[Federal Register Volume 86, Number 8 (Wednesday, January 13, 2021)]
[Proposed Rules]
[Pages 2633-2636]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28884]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
45 CFR Part 5b
[Docket Number NIH-2016-0002]
RIN 0925-AA62
Privacy Act; Implementation
AGENCY: Department of Health and Human Services.
ACTION: Notice of Proposed Rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS or
Department) proposes to exempt confidential source identifying
information in a system of records maintained by the National
Institutes of Health (NIH) from certain requirements of the Privacy
Act. The affected system of records is 09-25-0165, ``National
Institutes of Health (NIH) Office of Loan Repayment and Scholarship
(OLRS) Record System, HHS/NIH/OD'' (to be renamed ``NIH Loan Repayment
Records''). Elsewhere in today's Federal Register, HHS/NIH has
published an updated system of records notice (SORN) for system 09-25-
0165 for public notice and comment.
DATES: Submit either electronic or written comments regarding this
document by March 15, 2021.
ADDRESSES: You may submit comments, identified by Docket Number NIH-
2015-0002, via any of the following methods:
Electronic Submission
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions provided for submitting comments.
Written Submission
Submit written submissions in the following ways:
Fax: 301-402-0169.
Mail: Daniel Hernandez, Acting NIH Regulations Officer,
Office of Management Assessment, National Institutes of Health, 6011
Executive Boulevard, Suite 601, MSC 7669, Rockville, MD 20852.
In order to ensure more timely processing of comments, HHS/NIH is
no
[[Page 2634]]
longer accepting notice of proposed rulemaking (NPRM) comments
submitted to the agency by email. HHS/NIH encourages you to continue to
submit electronic comments by using the Federal eRulemaking Portal, as
described previously, in the ADDRESSES portion of this document under
Electronic Submissions.
Instructions: All submissions received must include the agency name
and Docket No. for this rulemaking. All comments received may be posted
without change to https://www.regulations.gov, including any personal
information provided.
Docket: For access to the docket to read background documents or
comments received, go to
https://www.regulations.gov and follow the instructions provided
for conducting a search, using the docket number found in brackets in
the heading of this document.
FOR FURTHER INFORMATION CONTACT: General questions about the proposed
exemptions may be submitted to Daniel Hernandez, Acting NIH Regulations
Officer, Office of Management Assessment, National Institutes of
Health, 6011 Executive Boulevard, Suite 601, MSC 7669, Rockville, MD
20852, telephone 301- 435-3343, fax 301-402-0169, email
[email protected].
SUPPLEMENTARY INFORMATION:
I. Background on the NIH Loan Repayment Programs and System of Records
09-25-0165
The NIH Loan Repayment Programs (LRPs) are administered by the
Division of Loan Repayment within NIH's Office of Extramural Research
(HHS/NIH/OER/DLR, hereafter referred to as DLR). DLR provides repayment
of student loans for approved applicants to encourage outstanding
health professionals to pursue careers in biomedical, behavioral,
social, and clinical research. Research health professionals who owe
qualified educational debt and who meet eligibility criteria may apply
for student loan repayment. Loan repayments utilize a peer review
process to determine which applicants to approve. The peer review
process is committee-based, with a peer review group comprised of
individual reviewers, referees, or other recommenders (hereafter
collectively referred to as reviewers). Reviewers are primarily non-
government experts qualified by training and experience in scientific
or technical fields, or as authorities knowledgeable in disciplines and
fields related to the areas under review. Reviewers give DLR expert
recommendations and materials (such as ratings, summaries, and
communications) about applicants' suitability, eligibility, or
qualifications for student loan repayments under express promises that
the reviewers will not be identified as the sources of the information.
DLR uses the information solely for the purpose of determining
applicants' suitability, eligibility, or qualifications for federal
loan repayment. System of records 09-25-0165 covers records about
health professionals who apply for student loan repayments and about
other categories of individuals who are related to the applications.
Records about those record subjects include materials and
recommendations provided to DLR by reviewers which identify, or could
enable identification of, those confidential sources.
II. Proposed Exemptions and Affected Records
HHS/NIH is proposing to exempt materials about LRP applicants in
system of records 09-25-0165 from certain provisions of the Privacy Act
(5 U.S.C. 552a). The exemption applies only to the extent that a
disclosure would reveal the identity of the reviewer or referee who
furnished information to the Government under an express promise that
his or her identity would be held in confidence. We propose to exempt
the system of records from (c)(3), pertaining to the accounting of
disclosures, and (d)(1) through (d)(4), pertaining to access,
amendment, and notification provisions, based on subsection (k)(5) of
the Act (5 U.S.C. 552a(k)(5)). Because records in system of records 09-
25-0165 contain information not only about applicants, but also about
the reviewers, the proposed exemptions are necessary to enable NIH to
prevent applicants from having access to information about the identity
of individuals who provided NIH with an expert review or referee report
under an express promise of confidentiality. Notwithstanding the
exemptions, NIH will consider any requests for notification, access,
and amendment that are addressed to the System Manager, as provided in
the SORN for system of records 09-25-0165, and to any request for an
accounting of disclosures.
Under the Privacy Act of 1974, as amended (5 U.S.C. 552a),
individuals have access and amendment rights with respect to records
about them in a federal agency system of records, and the right to seek
an accounting of certain disclosures made of the records about them,
but the Act permits certain types of systems of records (identified in
subsections (j) and (k) of the Act) to be exempted from those
requirements of the Act. Subsection (k)(5) permits the head of an
agency to promulgate rules to exempt from the requirements in 5 U.S.C.
552a(c)(3) and (d)(1) through (4) investigatory material compiled
solely for the purpose of determining suitability, eligibility, or
qualifications for access to federal civilian employment, military
service, federal contracts, or access to classified information, to the
extent that the disclosure of such material would reveal the identity
of a source who furnished information to the government under an
express promise that the identity of the source would be held in
confidence. Referee reports and reviews in system of records 09-25-0165
qualify for exemption under 5 U.S.C. 552a(k)(5), when provided to DLR
under an express promise of confidentiality, because it is
investigatory material that DLR compiles solely for the purpose of
determining applicants' suitability, eligibility, or qualifications for
federal loan repayment awards, which are implemented by contracts.
III. Exemption Rationales
The proposed exemptions are necessary to maintain the integrity of
the DLR peer review and award processes, which depend on receiving
accurate, objective, and unbiased recommendations and evaluations from
reviewers about loan repayment applications. Protecting reviewer
identities as the sources of the information they provide protects them
from harassment, intimidation, and other attempts to improperly
influence award outcomes, and ensures that they are not reluctant to
provide sensitive information or frank assessments. Case law has held
that exemptions promulgated under subsection (k)(5) may protect source-
identifying material even where the identity of the source is known to
the subject individual(s).
The specific rationales that support the exemptions, as to each
affected Privacy Act provision, are as follows:
Subsection (c)(3). An exemption from the requirement to
provide an accounting of disclosures to record subjects is needed to
protect the identity of any reviewer source who is expressly promised
confidentiality. Providing an accounting of disclosures to an
individual who is related to the application under assessment or
evaluation could identify particular reviewers as sources of
recommendations or evaluative input received, or to be received, on the
application. Inappropriately revealing their identities in association
with the nature and scope of their assessments or
[[Page 2635]]
evaluations could lead them to alter or destroy their assessments or
evaluations or subject them to harassment, intimidation, or other
improper influence, which would impede or compromise the fairness and
objectivity of the loan repayment application review process.
Subsection (d)(1). An exemption from the access
requirement is needed both during and after an award application review
proceeding to avoid inappropriately revealing the identity of any
source who was expressly promised confidentiality. Protecting these
records from access by record subjects is necessary for the integrity
of the review process. It ensures such sources provide candid
assessments or evaluations to the government without fear that their
identities as linked to a specific work product will be revealed
inappropriately. Allowing an individual applicant who is the subject of
an assessment or evaluation, or another record subject who has a
relationship to the application, to access material that would reveal a
reviewer could interfere with or compromise the objectivity and
fairness of award application review proceedings, constitute an
unwarranted invasion of the personal privacy of the reviewer, and
violate the express promise of confidentiality made to the reviewer.
Subsection (d)(2) through (4). An exemption from the
amendment provisions is necessary while one or more related application
review proceedings are pending, but only if and to the extent that
disclosure of information in the amendment request process would reveal
inappropriately the identity of any reviewer source who was expressly
promised confidentiality. An exemption will be limited to allowing the
agency, when processing an amendment request by an applicant or other
subject individual, to avoid disclosing the existence of the record
sought to be amended and its contents, if doing so would reveal the
identity of any reviewer who was expressly promised confidentiality.
Revealing the identity of a reviewer to an individual applicant or
other subject individual would interfere with the agency's application
review process and constitute an unwarranted invasion of the personal
privacy of the reviewer and would violate the express promise of
confidentiality made to the reviewer.
Accordingly, pursuant to 5 U.S.C. 552a(k)(5), NIH proposes to
exempt records about particular LRP applicants in system of records 09-
25-0165 NIH Division of Loan Repayment Record System from the access,
amendment, and accounting of disclosures provisions of the Privacy Act
(5 U.S.C. 552a(c)(3) and (d)(1) through (4)), to the extent, and based
on the specific rationales stated above. Notwithstanding the
exemptions, NIH will consider any request for access or amendment that
is addressed to the System Manger as provided in the SORN for system of
records 09-25-0165, and to any request for an accounting of
disclosures.
Analysis of Impacts
I. Review Under Executive Orders 12866, 13563, and 13771
The agency has reviewed this proposed rule under Executive Orders
12866 and 13563, which direct agencies to assess costs and benefits of
available regulatory alternatives and, if regulation is necessary, to
maximize the net benefits. The agency believes that this proposed rule
is not a significant regulatory action under Executive Order 12866, and
therefore does not constitute an E.O. 13771 regulatory action, because
it will not (1) have an annual effect on the economy of $100 million or
more or adversely affect in a material way the economy, a sector of the
economy, productivity, competition, jobs, the environment, public
health or safety, or state, local or tribal governments or communities;
(2) create a serious inconsistency or otherwise interfere with an
action taken or planned by another agency; (3) materially alter the
budgetary impact of entitlements, grants, user fees or loan programs,
or the rights and obligations of recipients thereof; or (4) raise novel
legal or policy issues arising out of legal mandates, the President's
priorities, or the principles set forth in Executive Order 12866. legal
mandates, the President's priorities, or the principles set forth in
Executive Order 12866. This rule removes certain Privacy Act rights
from the subjects of these records in accordance with criteria
established in subsection (k)(5) of the Privacy Act (5 U.S.C.
552a(k)(5)). This decision is based on a showing that agency compliance
with all of the Privacy Act requirements with respect to those records
would harm the effectiveness or integrity of the agency function or
process for which the records are maintained (in this case, NIH
research and development loan award processes).
II. Review Under the Regulatory Flexibility Act (5 U.S.C. 601-612)
The Regulatory Flexibility Act requires agencies to analyze
regulatory options that would minimize any significant regulatory
impacts of a rule on small entities. Because the proposed rule imposes
no duties or obligations on small entities, we have determined, and the
Director certifies, that the proposed rule will not have a significant
economic impact on a substantial number of small entities.
III. Review Under the Unfunded Mandates Reform Act of 1995 (Section
202, Pub. L. 104-4)
Section 202(a) of the Unfunded Mandates Reform Act of 1995 requires
that agencies prepare a written statement, which includes an assessment
of anticipated costs and benefits, before proposing ``any rule that
includes any Federal mandate that may result in the expenditure by
state, local, and tribal governments, in the aggregate, or by the
private sector, of $100,000,000 or more (adjusted annually for
inflation) in any one year.'' The current threshold after adjustment
for inflation is $144 million, using the most current (2015) Implicit
Price Deflator for the Gross Domestic Product. The agency does not
expect that this proposed rule would result in any 1-year expenditure
by state, local, and tribal governments that would meet or exceed this
amount.
IV. Review Under the Paperwork Reduction Act of 1995 (44 U.S.C. 35-1 et
seq.)
This proposed rule does not contain any information collection
requirements subject to the Paperwork Reduction Act.
V. Review Under Executive Order 13132, Federalism
This proposed rule will not have any direct effects on the states,
on the relationship between the National Government and the states, or
on the distribution of power and responsibilities among the various
levels of government. Therefore, the requirements of Executive Order
13132 are inapplicable.
List of Subjects in 45 CFR Part 5b
Privacy.
For the reasons set out in the preamble, the Department amends part
5b of title 45 of the Code of Federal Regulations, as follows:
PART 5b--PRIVACY ACT REGULATIONS
0
1. The authority citation for Part 5b continues to read as follows:
Authority: 5 U.S.C. 301, 5 U.S.C. 552a.
0
2. Amend Sec. 5b.11 by adding paragraph (b)(2)(iv)(D) as follows:
Sec. 5b.11 Exempt systems.
* * * * *
(b) * * *
[[Page 2636]]
(2) * * *
(iv)
(D) NIH Division of Loan Repayment Record System, 09-25-0165.
Dated: November 20, 2020.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
Approved: December 22, 2020.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2020-28884 Filed 1-12-21; 8:45 am]
BILLING CODE 4140-01-P